Results 101 to 110 of about 7,354 (172)

Elexacaftor/Tezacaftor/Ivacaftor in Children with Cystic Fibrosis: No Longer "If" but a Question of "When" to Start. [PDF]

Am J Respir Crit Care Med
Selvadurai H.
europepmc   +1 more source

Impact of Elexacaftor–Tezacaftor–Ivacaftor Therapy on Body Composition, Dietary Intake, Biomarkers, and Quality of Life in People with Cystic Fibrosis: A Prospective Observational Study

Francisco Hevilla, Nuria Porras, María Victoria Girón, María García‐Olivares, Marina Padial, Francisco José Sánchez-Torralvo, Casilda Olveira, Gabriel Olveira   +7 more
openalex   +1 more source

Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR [PDF]

, 2017
Jennifer L. Taylor‐Cousar, Manu Jain, Tara Lynn Barto, Tarik Haddad, Jeffrey J. Atkinson, Simon Tian, Rui Tang, Gautham Marigowda, David Waltz, Joseph M. Pilewski   +9 more
openalex   +1 more source

Successful Pregnancy in a Cystic Fibrosis Patient with a Severe Impairment of Lung Function Receiving Elexacaftor-Tezacaftor-Ivacaftor

, 2022
Zisis Balmpouzis, Annabelle Faure van Rossum, David Baud, Alice Panchaud, Georgia Mitropoulou, Jesica Mazza Stalder, Angela Koutsokera   +6 more
openalex   +1 more source

A systematic review and meta-analysis of the treatment modalities available for children afflicted from cystic fibrosis. [PDF]

BMC Pediatr
Alruwaili TAM, Alanazi MF, Alruwaili BF, Fayed HK, Elsaeed M, Alnazi TD, Aljared A, Alanazi AMW, Alanazi AM, Alsharari SD, Alshammari A, Saad K.   +11 more
europepmc   +1 more source

Investigation of the effects of the CFTR potentiator ivacaftor on human P-glycoprotein (ABCB1) [PDF]

, 2017
Swathi Lingam, Nopnithi Thonghin, Robert C. Ford   +2 more
openalex   +1 more source

Structural changes in lung morphology detected by MRI after modulating therapy with elexacaftor/tezacaftor/ivacaftor in adolescent and adult patients with cystic fibrosis

, 2023
Valentina Fainardi, Kaltra Skenderaj, Andrea Ciuni, Gianluca Milanese, Michela Deolmi, Francesco Longo, Cinzia Spaggiari, Nicola Sverzellati, Susanna Esposito, Giovanna Pisi   +9 more
openalex   +1 more source

Case Series on the Combined Therapy with Elexacaftor/Tezacaftor/Ivacaftor During Pregnancy in Women with Severe Cystic Fibrosis: A Retrospective Report from an Italian Centre. [PDF]

J Clin Med
Iacotucci P, Somma J, Ferrillo L, Celardo A, Conti V, Carlo CD, Rengo G, Corbi G, Carnovale V.   +8 more
europepmc   +1 more source

Welsh, González, and Negulescu share Lasker Award recognizing transformative treatments for people with cystic fibrosis. [PDF]

J Clin Invest
Singer BD, Budinger GRS.
europepmc   +1 more source

WS15.6 A phase 3, open-label study of tezacaftor/ivacaftor (TEZ/IVA) therapy: interim analysis of pooled safety, and efficacy in patients heterozygous for F508del-CFTR and a residual function mutation

, 2018
Patrick A. Flume, C.A. Owen, Reta Fischer Biner, C Simard, D.G. Downey, Hui Zhou, Julie Lekstrom-Himes, K. De Boeck   +7 more
openalex   +1 more source